An antibody targeting the n-terminal domain of sars-cov-2 disrupts the spike trimer vanderbilt vaccine center and 2department

HIGHLIGHTS

• who: Naveenchandra Suryadevara and collaborators from the Vanderbilt University of Medicine, StLouis, Missouri, USA. have published the paper: An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer Vanderbilt Vaccine Center and 2Department, in the Journal: (JOURNAL)
• what: This study provides insight into antibody targeting of the S protein TI region suggesting this region may be a site of virus vulnerability. The authors report the isolation and characterization of SARS-CoV-2-neutralizing mAbs targeting the NTD using LIBRASeq
• how: The results indicated that a dominant human B . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.